Pregabalin plus venlafaxine for fibromyalgia pain
Official title: Comparing the Efficacy and Safety of Pregabalin Monotherapy With Pregabalin Combined Other Neuromodulatory Drugs (Venlafaxine) in the Treatment of Fibromyalgia: A Multicenter Clinical Study
Run by Beijing Tiantan Hospital · NCT07186751 · Data updated 2026-11-12
This trial tests whether adding venlafaxine to pregabalin gives better pain relief for adults with moderate-to-severe fibromyalgia than pregabalin alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 750 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 2 sites (Beijin and 1 other locations) |
| Status | Recruiting |
| Started | September 20, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT07186751 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with fibromyalgia by 2016 criteria who have moderate-to-severe pain (NRS > 4) and are not currently receiving recommended pharmacologic treatment for fibromyalgia are appropriate candidates.
✕Probably not a fit
People who are pregnant or breastfeeding, have psychiatric illness, contraindications to pregabalin or venlafaxine, uncontrolled major medical conditions, or other pain disorders are unlikely to benefit or are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults who meet the 2016 fibromyalgia diagnostic criteria and report moderate-to-severe pain will receive either pregabalin alone or pregabalin combined with venlafaxine. The study compares pain reduction on an 11-point numeric rating scale and tracks adverse events to evaluate safety. Key exclusions include psychiatric disorders, pregnancy or breastfeeding, significant uncontrolled systemic disease, and other acute or chronic pain conditions. Participants will attend clinic visits at the study sites for drug administration and regular outcome assessments over the treatment period.
Why it matters
Potential benefit: If successful, the combination could provide greater pain relief than pregabalin alone without a meaningful increase in side effects.
How similar studies have gone: SNRIs such as duloxetine and some studies of venlafaxine have shown benefit in fibromyalgia, but evidence for combining venlafaxine with pregabalin is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with FM according to the 2016 Revisions to the 2010/2011 FM diagnostic criteria; * Aged more than 18 years; * Suffering from moderate to severe FM with 11-point numeric rating scale (NRS) score more than 4 at baseline that have not been effectively alleviated by non-pharmacological treatments and has not received currently recommended pharmacological treatment for FM; * Agreed to sign the informed consent form. Exclusion criteria * A history of psychiatric disease; * Hypersensitivity or have contraindications to pregabalin, venlafaxine; * Pregnancy or breastfeeding; * Presence of serious systemic diseases, including uncontrolled hypertension, uncontrolled diabetes, significant cardiac dysfunction, or chronic hepatic or renal dysfunction; * With acute or chronic pain conditions other than FM.
Where it's running
-
Beijing Tiantan Hospital, Beijing, Beijing 100070
Beijin, China Recruiting -
Beijing Tiantan Hospital, Beijing, Beijing 100070
Beijing, China Recruiting
Study contacts
- Study coordinator: Fang Luo
- Email: 13611326978@163.com
- Phone: +8613611326978
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregabalin plus dexmedetomidine for reducing pain and improving sleep in fibromyalgia
This trial will try combining pregabalin with dexmedetomidine to reduce pain and improve sleep in adults with moderate-to-severe fibromyalgia.
-
Pregabalin combined with toludesvenlafaxine for fibromyalgia pain
This trial will see if adding toludesvenlafaxine to pregabalin improves pain relief without causing more side effects for adults with moderate to severe fibromyalgia.
-
Pregabalin versus crisugabalin for fibromyalgia pain
This trial will test whether pregabalin or the newer drug crisugabalin reduces moderate-to-severe fibromyalgia pain in adults who have not yet used recommended fibromyalgia medications.
-
Pregabalin plus desvenlafaxine for fibromyalgia pain
This test will try whether adding desvenlafaxine to pregabalin gives better pain relief for adults with moderate to severe fibromyalgia.
-
Comparing pregabalin and mirogabalin for fibromyalgia pain
This trial will test whether mirogabalin or pregabalin better reduces pain and causes fewer side effects in adults with moderate-to-severe fibromyalgia.
-
Respiratory Function in Fibromyalgia: A Look at Breath and Muscle Health in Women
This study compares respiratory function, muscle strength, and quality of life between women with fibromyalgia and healthy women to see if fibromyalgia affects breathing and muscle performance.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.